Abstract PR005: Tepotinib + osimertinib in EGFR -mutant NSCLC with MET amplification following first-line osimertinib: INSIGHT 2 primary analysis von Le, Xiuning, Kim, Tae Min, Guarneri, Valentina, Voon, Pei Jye, Lim, Boon Khaw, Yang, Jinji, Wislez, Marie, Huang, Cheng, Liam, Chong Kim, Mazieres, Julien, Tho, Lye Mun, Hayashi, Hidetoshi, Nhung, Nguyen, Chia, Puey Ling, De Marinis, Fillippo, Raskin, Jo, Zhou, Qinghua, Finochhiaro, Giovanna, Tan, Daniel, Brutlach, Sabine, O'Brate, Aurora, Adrian, Svenja, Berghoff, Karin, Ellers-Lenz, Barbara, Karachaliou, Niki, Wu, Yi-Long

Volltext

Non-classical Bordetella sp. (closely related to Bordetella hinzii and Bordetella pseudohinzii) lower respiratory tract infection in a patient with extensive bronchiectasis: a case... von Loong, Shih Keng, Liam, Chong Kin, Karunakaran, Rina, Tan, Kim-Kee, Mahfodz, Nur Hidayana, AbuBakar, Sazaly

Volltext

Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study von Chai, Chee-Shee, Mos, Sumastika Bt, Ng, Diana-Leh-Ching, Goh, Greta-Miranda-Kim-Choo, Su, Anselm-Ting, Ibrahim, Muhammad Amin B, Musa, Aisya Natasya Bt, Tan, Seng-Beng, Pang, Yong-Kek, Liam, Chong-Kin

Volltext

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (IN... von Wu, Yi-Long, Cheng, Ying, Zhou, Jianying, Lu, Shun, Zhang, Yiping, Zhao, Jun, Kim, Dong-Wan, Soo, Ross Andrew, Kim, Sang-We, Pan, Hongming, Chen, Yuh-Min, Chian, Chih-Feng, Liu, Xiaoqing, Tan, Daniel Shao Weng, Bruns, Rolf, Straub, Josef, Johne, Andreas, Scheele, Jürgen, Park, Keunchil, Yang, James Chih-Hsin, Liu, Zhe, Chen, Xi, Wang, Mengzhao, Yu, Shiying, Zhang, Helong, Fang, Jian, Li, Wei, Yang, Chih-Hsin, Chang, Gee-Chen, Hsia, Te-Chun, Yang, Cheng-Ta, Wang, Chin-Chou, Cho, Byoung Chul, Lee, Ki Hyeong, Kim, Young-Chul, An, Ho Jung, Woo, In Sook, Cho, Jae Yong, Shin, Sang Won, Lee, Jong-Seok, Kim, Joo-Hang, Yoo, Seung Soo, Kato, Terufumi, Shinagawa, Naofumi, Tan, Shao Weng Daniel, Ngo, Lynette Si-Mien, Ratnavelu, Kananathan, Ahmad, Azura Rozila, Liam, Chong Kin, de Marinis, Filippo, Tassone, Pierfrancesco, Molla, Amelia Insa, Calles Blanco, Antonio, Lazaro Quintela, Martin Emilio, Felip Font, Enriqueta, Dingemans, Anne-Marie, Bui, Lynne

Volltext

Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentr... von Wu, Yi-Long, Guarneri, Valentina, Voon, Pei Jye, Lim, Boon Khaw, Yang, Jin-Ji, Wislez, Marie, Huang, Cheng, Liam, Chong Kin, Mazieres, Julien, Tho, Lye Mun, Hayashi, Hidetoshi, Nhung, Nguyen Viet, Chia, Puey Ling, de Marinis, Filippo, Raskin, Jo, Zhou, Qinghua, Finocchiaro, Giovanna, Le, Anh Tuan, Wang, Jialei, Dooms, Christophe, Kato, Terufumi, Nadal, Ernest, Hin, How Soon, Smit, Egbert F, Wermke, Martin, Tan, Daniel, Morise, Masahiro, O'Brate, Aurora, Adrian, Svenja, Pfeiffer, Boris M, Stroh, Christopher, Juraeva, Dilafruz, Strotmann, Rainer, Goteti, Kosalaram, Berghoff, Karin, Ellers-Lenz, Barbara, Karachaliou, Niki, Le, Xiuning, Kim, Tae Min

Volltext

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis von Liam, Chong Kin, Ahmad, Azura Rozila, Hsia, Te-Chun, Zhou, Jianying, Kim, Dong-Wan, Soo, Ross Andrew, Cheng, Ying, Lu, Shun, Shin, Sang Won, Yang, James Chih-Hsin, Zhang, Yiping, Zhao, Jun, Berghoff, Karin, Bruns, Rolf, Johne, Andreas, Wu, Yi-Long

Volltext

Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations von Ahn, Myung-Ju, Mendoza, Marvin Jonne L., Pavlakis, Nick, Kato, Terufumi, Soo, Ross A., Kim, Dong-Wan, Liam, Chong Kin, Hsia, Te-Chun, Lee, Chee Khoon, Reungwetwattana, Thanyanan, Geater, Sarayut, Chan, Oscar Siu Hong, Prasongsook, Naiyarat, Solomon, Benjamin J., Nguyen, Thi Thai Hoa, Kozuki, Toshiyuki, Yang, James Chih-Hsin, Wu, Yi-Long, Mok, Tony Shu Kam, Tan, Daniel Shao-Weng, Yatabe, Yasushi

Volltext

Tepotinib + osimertinib for EGFR mutant (EGFR m) NSCLC with MET amplification ( MET amp) after first-line (1L) osimertinib von Tan, Daniel Shao-Weng, Kim, Tae Min, Guarneri, Valentina, VOON, PEI JYE, Lim, Boon Khaw, Wislez, Marie, Huang, Cheng, Liam, Chong Kin, Mazieres, Julien, Tho, Lye Mun, Hayashi, Hidetoshi, Nhung, Nguyen, Chia, Puey Ling, de Marinis, Filippo, Le, Xiuning, Karachaliou, Niki, Brutlach, Sabine, Adrian, Svenja, Ellers-Lenz, Barbara, Wu, Yi-Long

Volltext

Non-classical sp. (closely related to and lower respiratory tract infection in a patient with extensive bronchiectasis: a case report von Shih Keng Loong, Chong Kin Liam, Rina Karunakaran, Kim-Kee Tan, Nur Hidayana Mahfodz, Sazaly AbuBakar

Volltext

PP01.84 Tepotinib + Osimertinib in EGFR-mutant NSCLC with MET Amplification Following 1L Osimertinib: INSIGHT 2 Primary Analysis von Kim, Tae Min, Guarneri, Valentina, Voon, Pei Jye, Lim, Boon Khaw, Yang, Jin-ji, Wislez, Marie, Huang, Cheng, Liam, Chong Kin, Mazieres, Julien, Tho, ye Mun, Hayashi, Hidetoshi, Nguyen, Nhung, Chia, Puey Ling, de Marinis, Filippo, Raskin, Jo, Zhou, Qinghua, Finocchiaro, Giovanna, Le, Xiuning, Tan, Daniel, O’Hara, Richard M., Brutlach, Sabine, O’Brate, Aurora, Adrian, Svenja, Berghoff, Karin, Ellers-Lenz, Barbara, Karachaliou, Niki, Wu, Yi-Long

Volltext

A Real-World Study to End Tyrosine Kinase Inhibitor in Chronic Myeloid Leukaemia (EnTIC) in Malaysia: One Year Follow-up of Multicenter Study in Malaysia von Chong, SiewLian, Ong, Tee Chuan, Asnawi, Wirda, Wong, Tien Gen, Ahmad Zakiyy, Mohamed, Tham, Yea Bing, Ahmad Shuyuti, Nur Aini Syakirah, Binti Syed Abd Kadir, Sharifah Shahnaz, Tan, Jerome, Ho, Kim Wah, Lau, Ngee Siang, Yee Yee, Yap, Selvaratnam, Veena, Tan, Sen Mui, Goh, Ai Sim, Teoh, Ching Soon, Keat, Sui, Lim, Soo Min, Sharif, Azizan, Boo, Yang Liang, Liam, Christopher, Kori, Ahlam Naila, Toh, See Guan, Gan, Ee Leng, Ng, Si Yuan, Hon, Siong Leng, Tan, Jenq Tzong

Volltext

Abstract CT538: Tepotinib + gefitinib in patients with EGFR -mutant NSCLC with MET amplification: Final analysis of INSIGHT von Liam, Chong Kin, Ahmad, Azura Rozila, Hsia, Te-Chun, Zhou, Jianying, Kim, Dong-Wan, Soo, Ross Andrew, Cheng, Ying, Lu, Shun, Shin, Sang Won, Yang, James Chih-Hsin, Zhang, Yiping, Zhao, Jun, Bruns, Rolf, Johne, Andreas, Wu, Yi-Long

Volltext

Causes of pleural exudates in a region with a high incidence of tuberculosis von Liam, Chong-Kin, Lim, Kim-Hatt, Wong, Catherine Mee-Ming

Volltext

Community-acquired pneumonia in patients requiring hospitalization von Liam, Chong-Kin, Lim, Kim-Hatt, Wong, Catherine Mee-Ming

Volltext

Skin prick test reactivity to common aeroallergens in asthmatic patients with and without rhinitis von LIAM, CHONG-KIN, LOO, KOK-LIM, WONG, CATHERINE MEE-MING, LIM, KIM-HATT, LEE, TONG-CHOW

Volltext

A 52-Year-Old Woman With Recurrent Hemoptysis von Lim, Kim-Hatt, Liam, Chong-Kin, Wong, Catherine Mee-Ming, Lim, Yew-Cheng

Volltext

Non-small Cell Lung Cancer in Very Young and Very Old Malaysian Patients von Liam, Chong-Kin, Lim, Kim-Hatt, Wong, Catherine Mee-Ming

Volltext

The causes of haemoptysis in Malaysian patients aged over 60 and the diagnostic yield of different investigations von WONG, Catherine Mee-Ming, LIM, Kim Hatt, LIAM, Chong-Kin

Volltext

Metastatic lung cancer in pregnancy von WONG, Catherine Mee‐Ming, LIM, Kim Hatt, LIAM, Chong‐Kin

Volltext

An Unusual Cause of Secondary Spontaneous Pneumothorax in a 27-Year-Old Man von Lim, Kim-Hatt, Tan, Lian-Huat, Liam, Chong-Kin, Wong, Catherine Mee-Ming

Volltext